Antengene Corporation Limited (6996.HK)
HKD 0.62
(0.0%)
HKD 0.62
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -461.31 Million CNY | 73.36% |
| 2022 | -1.73 Billion CNY | 23.38% |
| 2021 | -2.25 Billion CNY | 27.07% |
| 2020 | -3.09 Billion CNY | -317.29% |
| 2019 | -742.63 Million CNY | -2171.53% |
| 2018 | -32.69 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -843.68 Million CNY | 0.0% |
| 2023 Q4 | -461.31 Million CNY | 0.0% |
| 2023 FY | -461.31 Million CNY | 73.36% |
| 2023 Q2 | -836.5 Million CNY | 0.0% |
| 2022 FY | -1.73 Billion CNY | 23.38% |
| 2022 Q4 | -621.57 Million CNY | 0.0% |
| 2022 Q2 | -1.06 Billion CNY | 0.0% |
| 2021 Q2 | -1.17 Billion CNY | 0.0% |
| 2021 FY | -2.25 Billion CNY | 27.07% |
| 2021 Q4 | -1.59 Billion CNY | 0.0% |
| 2020 Q2 | 1.07 Billion CNY | 0.0% |
| 2020 FY | -3.09 Billion CNY | -317.29% |
| 2020 Q4 | -3.67 Billion CNY | 0.0% |
| 2019 Q2 | - HKD | 0.0% |
| 2019 Q4 | 589.33 Million CNY | 0.0% |
| 2019 FY | -742.63 Million CNY | -2171.53% |
| 2018 FY | -32.69 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | -76.36 Million HKD | -504.061% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 108.759% |